We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$151M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$48.3M
3
ITOS
iTeos Therapeutics
ITOS
+$21.3M
4
QNGY
Quanergy Systems, Inc.
QNGY
+$11.5M
5
FULC icon
Fulcrum Therapeutics
FULC
+$10.9M

Top Sells

Rank Stock Value
1
SMH icon
VanEck Semiconductor ETF
SMH
+$30.8M
2
DIS icon
Walt Disney
DIS
+$23.1M
3
NGHC
National General Holdings Corp
NGHC
+$20.7M
4
STLA icon
Stellantis
STLA
+$19.7M
5
SVOKU
Seven Oaks Acquisition Corp. Unit
SVOKU
+$16M

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSAT icon
576
Globalstar
GSAT
$10.8B
– –
-8,457
Closed -$43K
HLMN icon
577
Hillman Solutions
HLMN
$1.75B
– –
-75,000
Closed -$786K
IBB icon
578
iShares Biotechnology ETF
IBB
$9.82B
– –
-127
Closed -$19K
IBB icon
579
PUT
iShares Biotechnology ETF
IBB
$9.82B
– –
-20,500
Closed -$2K
IFF icon
580
International Flavors & Fragrances
IFF
$21.7B
– –
-50,000
Closed -$5.44M
IFF icon
581
PUT
International Flavors & Fragrances
IFF
$21.7B
– –
-78,700
Closed -$2.26M
INSM icon
582
CALL
Insmed
INSM
$28.9B
– –
-8,500
Closed -$47K
INSM icon
583
PUT
Insmed
INSM
$28.9B
– –
-3,500
Closed -$5K
IOVA icon
584
CALL
Iovance Biotherapeutics
IOVA
$2.92B
– –
-35,000
Closed -$120K
IRWD icon
585
CALL
Ironwood Pharmaceuticals
IRWD
$701M
– –
-10,000
Closed -$4K
JOBY icon
586
Joby Aviation
JOBY
$8.35B
– –
-20,000
Closed -$231K
JSPR icon
587
Jasper Therapeutics
JSPR
$30.2M
– –
-2,500
Closed -$250K
JSPRW icon
588
Japer Therapeutics Warrants
JSPRW
$216K
– –
-15,000
Closed -$22K
LPX icon
589
CALL
Louisiana-Pacific
LPX
$5.28B
– –
-126,200
Closed -$149K
LPX icon
590
Louisiana-Pacific
LPX
$5.28B
– –
-178,229
Closed -$6.63M
LPX icon
591
PUT
Louisiana-Pacific
LPX
$5.28B
– –
-108,700
Closed -$104K
M icon
592
PUT
Macy's
M
$6.46B
– –
-118,200
Closed -$1K
MCD icon
593
McDonald's
MCD
$193B
– –
-1,733
Closed -$372K
MCD icon
594
PUT
McDonald's
MCD
$193B
– –
-15,900
Closed -$115K
META icon
595
CALL
Meta Platforms (Facebook)
META
$1.53T
– –
-800
Closed -$5K
META icon
596
Meta Platforms (Facebook)
META
$1.53T
– –
-14,243
Closed -$3.89M
META icon
597
PUT
Meta Platforms (Facebook)
META
$1.53T
– –
-15,000
Closed -$89K
MP icon
598
MP Materials
MP
$9.8B
– –
-13,361
Closed -$430K
MP icon
599
PUT
MP Materials
MP
$9.8B
– –
-90,300
Closed -$524K
MRSN
600
CALL
DELISTED
Mersana Therapeutics
MRSN
– –
-476
Closed -$16K
22 23
24
25 26

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.